MDB Capital Announces Record Date Of July 22, 2024 For IPO Of 4.3M Shares Of Common Stock For Invizyne Technologies At A Price Of $4/Share
MDB Capital Announces Record Date Of July 22, 2024 For IPO Of 4.3M Shares Of Common Stock For Invizyne Technologies At A Price Of $4/Share
- Record date of July 22, 2024 set for allocation preferences
- Closing and trading expected on NASDAQ on or before August 15
- 2024年7月22日设定分配偏好的记录日期。
- 预计在或者在8月15日前于纳斯达克关闭和交易。
Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and expected timeline for the proposed offering for Invizyne Technologies, Inc.
2024年7月11日得克萨斯州艾迪逊（GLOBE NEWSWIRE）- MDb Capital Holdings，LLC，（NASDAQ：MDBH）（“MDB”），一家公共创业平台，专注于推出领先的深科技公司，今天宣布了Invizyne Technologies，Inc.拟议中发行的记录日期、分配偏好和预期时间表。
In February 2024, Invizyne – a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life and a subsidiary of MDB Capital Holdings – filed its IPO registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for the sale of its common stock in a firm commitment public offering.
2024年2月，Invizyne – 一家领先的电芯无细胞、基于酶的生物制造系统设计公司，专门为生产日常生活中的商业化重要分子和化学药品，是MDB Capital Holdings的子公司-以形式S-1向美国证券交易委员会（“SEC”）提交其首次公开发行注册声明，出售其普通股。